Member Info for violindog

C7 asked about the frequency of these 72 trades....they keep being printed 🤔

"The panel of mAbs tested included FG27 and ch88.2 provided

by Professor Lindy Durrant (Scancell UK, University of Nottingham UK)"

Hi Cleaner, I was wondering if that is the glymab from Scancell that is currently under exclusive review ? If it can block the helicobacter bacteria and result in a vaccine to prevent stomach cancer ...ie similar to the one used for cervical cancer ???

TF, thanking you for your thoughts, get back to you on that ... but not now .

Https://link.springer.com/article/10.1038/s41598-024-59234-w/tables/2

The panel of mAbs tested included FG27 and ch88.2 provided by Professor Lindy Durrant (Scancell UK, University of Nottingham UK),

C7....Shana Tov Umekah to you, your family... and to everyone.

UCLH... I have very fond memories of working at the original UCH and I was there during its merger with the Middlesex hospital which subsequently became UCLH. The rivalry between UCH and the Middlesex was strong...and each had its "own pub" . I had many drinks at the Jeremy Betham . Fond memories x Interesting fact for you C7, the Middlesex had a large proportion of Jewish patients. I wonder if we ever crossed paths during my time in London.

Sometimes , I do post to try and provoke debate but I fully admit to being totally frustrated with this investment....I am in awe of the science but the timescale and disappointment in sustaining a decent SP has taken the passion away . I miss your posts as you inspired my first investment in Scancell and i would love you to have retained a small holding. I'm sure it was hard for you watching the rise to 19p but it's been harder enduring the fall back to 12.5p . I am... by Western standards... very, very lucky and I live a comfortable life, and the pain the World is currently enduring makes me feel even more blessed..... but time is against me ...and I would love to realise some decent profit. At this stage of my life its no longer for my own expectations or dreams, that boat has sailed : (( Now , I would receive more joy gifting the money but April 2025 is my cut off and I am really feeling the pressure of time !

The disconect between the current share price, the valuation from Trinity, and the expectations of a decent rise post results is, in the words of Vulps....truly derisory indeed. Yet another 0.25 mark down to 12.5 pence despite all the conferences , initial results, and in the words of LD " interested parties" .

Matt, why would any of them buy and help lift confidence.... they have their option freebies at no risk to their capital unlike us shareholders.

Scancell simply can't complete with major pharmas when it comes to finance etc....but we may, just may , have the edge when it comes to scib and Moditope.

LTH shareholders financed Scancell to this point and we were rescued by Redmiles investment along the way. Scancell has transformed from a research outfit to a company with great potential. Its simply brilliant that a minow like Scancell have got to the point where we are now on a tight budget .... the next few months and Q1 next year will shape the future ..boom or bust !

Oxford uni Ovarian cancer vax sponsored by CRUK in the media today . Shame they don't latch onto the initial ovarian cancer vax results from Scancell... what is it now...60% stable disease?

Guess any cancer vax publicity is good for us.

Hopefully when the completion of the SCOPE and Moditope trials are out ...LD , Scancell and the media will run the story and our SP will get a boost and deals to follow. As long as we don't hear the phrase "pushing at open doors" ...I just may achieve my target price 🤣

Don't know if you read this bb... so...could someone please paste this on the other BB.

Moljen, sorry to read your news about your dad. Firstly, see if your dad's hospital is one of the trial sites. Remember, your dad can insist with his GP to be treated at a hospital of his choice. All hospitals that run clinical trials will have research nurses. A main part of their role is to recruit patients... it may sound odd to the lay person but they will have a far greater insight into the potential eligibility ...more so than the patients medical team. Research nurses will have the "power" to commence bloods, investigations and refer to trial medical teams. They don't need the patients named Consultant agreeing to the patient being enrolled into the trial. This is because hospitals receive so much money for each patient recruited....hence trial nurses trawl for patients and individual medical teams can not obstruct the process. They will most likely trawl the data of any new patient and make assessments for eligibility... and then directly approach the patient. So , if your dad's hospital is a Moditope trial hospital the research nurses will most likely review his medical notes and assess if he is suitable for the trial. But its well worth asking to speak to a trial nurse and asking what the current options are available. Also , ask the medical team about any trials available, cover all options.

Wishing you both all my best. Golden rule for getting the best NHS treatment....be kind and polite... but at the same time be passively aggressive .

Some potential early dates next year ..stress on the EARLY 🙏🙏JPMorgan (date tbc) and the BIO in Feb and a potential in April .... Unless we get something beforehand..

https://www.biopharmadive.com/news/top-biotech-pharma-medical-conferences-2025/728449/

"With rare exceptions, biotechnology and pharmaceutical companies validate their business plans through clinical trials, results from which are often presented and dissected at medical conferences throughout the year. These are the forums where executives get to showcase the “proof of concept” they so frequently talk about.

Some meetings tend to spotlight the early human research that first indicates a new treatment’s potential. Others are for the late-stage study findings that can pave the way toward regulatory approval.

Below, BioPharma Dive has collected schedules for the key medical meetings remaining in 2024 and planned in 2025, as well as for a few key industry events."

Top medical and industry meetings in 2024 and 2025

The tree shake seams to be going on from 19p.... I can't believe we are now down to 13p. It could easily go back to sub 10p before any news 😦 .I'm a totally fed up !!

-0.75 - 5.17% ... folks will begin to dread any RNS from Scancell...always accompanied by a fall these days.

Well done Moonparty....its just us LTHs around at the moment nibbling afew more.

Hard to think some of this is not going on ??

Every RNS of late is immediately followed by at least a 0:25 % fall ....and frequent small sells. The advertised spread is awfull @11% .

With the fall from 19p there's certainly no new buyers post the investors presentation after the accounts. Guess investors have either taken their positions or are happy to pay more post the SCOPE results. Depressing....we now need a 15% rise just to get us back to 19p where we were last month . As ever ...its the large pharma deal that we need !!

Jam... but I guess that there is nothing to stop a pharma saying "we will offer this amount of payment if SCOPE achieves this goal" and they ask Scancell to sign a deal based on this and both parties await results. But would Scancell agree and shut out potential rival offers once data is known ???

Jam, I think others have posted LD saying something to the affect " interested parties are waiting for results " This isn't a direct quote but it was something like this.

Re NDAs ... I don't believe that they could circumvent stock exchange rules re disclosure of price sensitive information . If other folks think otherwise I stand to be corrected is certainly not my area of expertise.

Hi Jam, third parties could not get info prior to shareholders... Scancell need to disclose to the market any price sensitive information..Good or bad !

Yes, we may have a cash balance to see us through to Q4 2025 but Scancell would need to plan and secure funds at least 6mts prior to this date.... If nothing else ...staff need security.

So hopefully all funding sorted by the end of Q1 next year. Wouldn't it be great if our interested pharma payed the sort of money Marcus keeps posting ( on the other BB) other companies have received for similar assets !! Just imagine our sp if we landed a 500million deal for the mAb 😀

16th October LD presenting in Switzerland.... 🤞Either it is just her turn for a trip away or we may get the news we are awaiting ....only two weeks away !!